- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2
- Meeting Date: May 2025
- Public Summary Document (PSD) May 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) May 2025 PBAC Meeting - (Word)
Raxtozinameran – May 2025
Raxtozinameran: I.M. injection, suspension for injection containing raxtozinameran 30 micrograms; Comirnaty® Omicron XBB.1.5
Last updated
9 May 2025